Houston-based co. ready to test COVID-19 ‘vaccine candidate,’ but doesn’t have the funds

This story excerpt is courtesy of our partners at KHOU 11. Click here for KHOU’s full story, and click here for more coronavirus coverage from KHOU.

HOUSTON — A Houston-based genetic engineering company says it’s ready to start animal testing of its COVID-19 vaccine candidate.

“When will we have the vaccine? That’s the one everybody wants to know,” said Greffex President and CEO John Price.“Nobody wants to wait 18 months. Nobody.”

Price said a vaccine candidate is a vaccine that still…